359 related articles for article (PubMed ID: 31265887)
1. Dissection of mechanisms of Chinese medicinal formula Si-Miao-Yong-an decoction protects against cardiac hypertrophy and fibrosis in isoprenaline-induced heart failure.
Zhao Y; Jiang Y; Chen Y; Zhang F; Zhang X; Zhu L; Yao X
J Ethnopharmacol; 2020 Feb; 248():112050. PubMed ID: 31265887
[TBL] [Abstract][Full Text] [Related]
2. Deciphering the effective combinatorial components from Si-Miao-Yong-An decoction regarding the intervention on myocardial hypertrophy.
Chen XY; Chen XH; Li L; Su CP; Zhang YL; Jiang YY; Guo SZ; Liu B
J Ethnopharmacol; 2021 May; 271():113833. PubMed ID: 33465437
[TBL] [Abstract][Full Text] [Related]
3. Main active components of Si-Miao-Yong-An decoction (SMYAD) attenuate autophagy and apoptosis via the PDE5A-AKT and TLR4-NOX4 pathways in isoproterenol (ISO)-induced heart failure models.
Liao M; Xie Q; Zhao Y; Yang C; Lin C; Wang G; Liu B; Zhu L
Pharmacol Res; 2022 Feb; 176():106077. PubMed ID: 35026404
[TBL] [Abstract][Full Text] [Related]
4. Si-Miao-Yong-An decoction ameliorates cardiac function through restoring the equilibrium of SOD and NOX2 in heart failure mice.
Ren Y; Chen X; Li P; Zhang H; Su C; Zeng Z; Wu Y; Xie X; Wang Q; Han J; Guo S; Liu B; Wang W
Pharmacol Res; 2019 Aug; 146():104318. PubMed ID: 31228552
[TBL] [Abstract][Full Text] [Related]
5. Si-Miao-Yong-An decoction attenuates cardiac fibrosis via suppressing TGF-β1 pathway and interfering with MMP-TIMPs expression.
Su C; Wang Q; Luo H; Jiao W; Tang J; Li L; Tian L; Chen X; Liu B; Yu X; Li S; Guo S; Wang W
Biomed Pharmacother; 2020 Jul; 127():110132. PubMed ID: 32403042
[TBL] [Abstract][Full Text] [Related]
6. Si-Miao-Yong-An Decoction attenuates isoprenaline-induced myocardial fibrosis in AMPK-driven Akt/mTOR and TGF-β/SMAD3 pathways.
Zhao Y; Sun D; Chen Y; Zhan K; Meng Q; Zhang X; Zhu L; Yao X
Biomed Pharmacother; 2020 Oct; 130():110522. PubMed ID: 32736236
[TBL] [Abstract][Full Text] [Related]
7. A metabolite of Danshen formulae attenuates cardiac fibrosis induced by isoprenaline, via a NOX2/ROS/p38 pathway.
Yin Q; Lu H; Bai Y; Tian A; Yang Q; Wu J; Yang C; Fan TP; Zhang Y; Zheng X; Zheng X; Li Z
Br J Pharmacol; 2015 Dec; 172(23):5573-85. PubMed ID: 25766073
[TBL] [Abstract][Full Text] [Related]
8. Effect of Si-Miao-Yong-An decoction on the differentiation of monocytes, macrophages, and regulatory T cells in ApoE
Chen XN; Ge QH; Zhao YX; Guo XC; Zhang JP
J Ethnopharmacol; 2021 Aug; 276():114178. PubMed ID: 33945857
[TBL] [Abstract][Full Text] [Related]
9. A plasma metabonomics study on the therapeutic effects of the Si-miao-yong-an decoction in hyperlipidemic rats.
Shi S; Liu Z; Xue Z; Chen X; Chu Y
J Ethnopharmacol; 2020 Jun; 256():112780. PubMed ID: 32222575
[TBL] [Abstract][Full Text] [Related]
10. Kidney-tonifying blood-activating decoction delays ventricular remodeling in rats with chronic heart failure by regulating gut microbiota and metabolites and p38 mitogen-activated protein kinase/p65 nuclear factor kappa-B/aquaporin-4 signaling pathway.
Xu R; Bi Y; He X; Zhang Y; Zhao X
J Ethnopharmacol; 2024 Aug; 330():118110. PubMed ID: 38580189
[TBL] [Abstract][Full Text] [Related]
11. Si-Miao-Yong-An Decoction Protects Against Cardiac Hypertrophy and Dysfunction by Inhibiting Platelet Aggregation and Activation.
Su C; Wang Q; Zhang H; Jiao W; Luo H; Li L; Chen X; Liu B; Yu X; Li S; Wang W; Guo S
Front Pharmacol; 2019; 10():990. PubMed ID: 31619988
[No Abstract] [Full Text] [Related]
12. Songling Xuemaikang Capsule inhibits isoproterenol-induced cardiac hypertrophy via CaMKIIδ and ERK1/2 pathways.
Qi J; Tan Y; Fan D; Pan W; Yu J; Xu W; Wu J; Zhang M
J Ethnopharmacol; 2020 May; 253():112660. PubMed ID: 32061912
[TBL] [Abstract][Full Text] [Related]
13. Promotion of classic neutral bile acids synthesis pathway is responsible for cholesterol-lowing effect of Si-miao-yong-an decoction: Application of LC-MS/MS method to determine 6 major bile acids in rat liver and plasma.
Liu Z; Zhang Y; Zhang R; Gu L; Chen X
J Pharm Biomed Anal; 2017 Feb; 135():167-175. PubMed ID: 28033554
[TBL] [Abstract][Full Text] [Related]
14. Plantamajoside attenuates isoproterenol-induced cardiac hypertrophy associated with the HDAC2 and AKT/ GSK-3β signaling pathway.
Shang L; Pin L; Zhu S; Zhong X; Zhang Y; Shun M; Liu Y; Hou M
Chem Biol Interact; 2019 Jul; 307():21-28. PubMed ID: 31009642
[TBL] [Abstract][Full Text] [Related]
15. Si-Miao-Yong-An Decoction Maintains the Cardiac Function and Protects Cardiomyocytes from Myocardial Ischemia and Reperfusion Injury.
Cui W; Xin S; Zhu L; Wang M; Hao Y; Zhao Y; Li Y; Hou Y
Evid Based Complement Alternat Med; 2021; 2021():8968464. PubMed ID: 34367308
[TBL] [Abstract][Full Text] [Related]
16. Xinmailong mitigated epirubicin-induced cardiotoxicity via inhibiting autophagy.
Li H; Mao Y; Zhang Q; Han Q; Man Z; Zhang J; Wang X; Hu R; Zhang X; Irwin DM; Niu G; Tan H
J Ethnopharmacol; 2016 Nov; 192():459-470. PubMed ID: 27586823
[TBL] [Abstract][Full Text] [Related]
17. Network pharmacology-based approach to research the effect and mechanism of Si-Miao-Yong-An decoction against thromboangiitis obliterans.
Zou J; Xu W; Li Z; Gao P; Zhang F; Cui Y; Hu J
Ann Med; 2023 Dec; 55(1):2218105. PubMed ID: 37318081
[TBL] [Abstract][Full Text] [Related]
18. Jia-Wei-Si-Miao-Yong-An Fang stimulates the healing of acute radiation-induced cutaneous wounds through MAPK/ERK pathway.
Wang Y; Gao J; Sun L; Li Q; Kang N; Gao C; Li T
J Ethnopharmacol; 2023 Apr; 306():116180. PubMed ID: 36693549
[TBL] [Abstract][Full Text] [Related]
19. Qishen granule attenuates cardiac fibrosis by regulating TGF-β /Smad3 and GSK-3β pathway.
Zeng Z; Wang Q; Yang X; Ren Y; Jiao S; Zhu Q; Guo D; Xia K; Wang Y; Li C; Wang W
Phytomedicine; 2019 Sep; 62():152949. PubMed ID: 31102891
[TBL] [Abstract][Full Text] [Related]
20. An animal research and a chemical composition analysis of a Chinese prescription for pulmonary fibrosis: Yangfei Huoxue Decoction.
Liu X; Chen H; Su G; Song P; Jiang M; Gong J
J Ethnopharmacol; 2019 Dec; 245():112126. PubMed ID: 31421181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]